BFOCX | FSELX | BFOCX / FSELX | |
Total Expense Ratio | 1.96 | 0.62 | 316% |
Annual Report Gross Expense Ratio | 1.96 | 0.62 | 316% |
Fund Existence | 28 years | 40 years | - |
Gain YTD | 20.337 | 9.979 | 204% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 296M | 21.8B | 1% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 63.77 | 15.39 | 414% |
Returns for 3 years | 129.16 | 132.70 | 97% |
Returns for 5 years | -3.19 | 205.28 | -2% |
Returns for 10 years | 72.79 | 378.77 | 19% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 65.54 | 0.24 | +0.37% |
Janus Henderson Global Life Sciences A | |||
FAOOX | 65.03 | 0.24 | +0.37% |
American Funds Invmt Co of Amer 529-F-3 | |||
NSIDX | 14.22 | 0.05 | +0.35% |
Northern Small Cap Index | |||
BRWSX | 27.12 | 0.08 | +0.30% |
MFS Blended Research Growth Eq R2 | |||
PGSLX | 11.68 | -0.01 | -0.09% |
Principal Global Listed Inf Inst |